0000899243-16-017816.txt : 20160408 0000899243-16-017816.hdr.sgml : 20160408 20160408170021 ACCESSION NUMBER: 0000899243-16-017816 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151209 FILED AS OF DATE: 20160408 DATE AS OF CHANGE: 20160408 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Butler John P. CENTRAL INDEX KEY: 0001591467 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 161563281 MAIL ADDRESS: STREET 1: C/O RELYPSA, INC. STREET 2: 700 SAGINAW DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2015-12-09 2015-12-10 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001591467 Butler John P. C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 1 0 0 0 Stock Options (Right to Buy) 4.50 2016-12-09 2025-12-09 Common Stock 50000 D The Form 3 originally filed on December 10, 2015 is being amended to remove the Common Stock (Restricted) that was incorrectly included on the original Form 3. The options vest as follows: 16,667 on December 9, 2016; 16,667 on December 9, 2017; and 16,666 on December 9, 2018. /s/ Brian Adams, Attorney-in-Fact 2016-04-08